US2016243117A1PendingUtilityA1

Host Defense Protein (HDP) Mimetics For Prophylaxis And/Or Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract

Assignee: CELLCEUTIX CORPPriority: Feb 20, 2015Filed: Feb 12, 2016Published: Aug 25, 2016
Est. expiryFeb 20, 2035(~8.6 yrs left)· nominal 20-yr term from priority
Inventors:Krishna Menon
A61P 37/00A61P 29/00A61P 1/04A61K 31/167A61K 45/06A61P 1/00A61K 31/506
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract in a mammal comprising administering to the mammal in need of such prophylaxis and/or treatment a therapeutically effective amount of a compound selected from PMX-30063 (brilacidin) and PMX-60056 (delparantag) and pharmaceutically acceptable salts thereof. 
     
     
         2 . A method according to  claim 1 , wherein the disease is inflammatory bowel disease, ulcerative colitis, collagenous colitis, lymphocytic colitis, Crohn's disease, or irritable bowel syndrome. 
     
     
         3 . A method according to  claim 1  wherein said compound is administered together with an antibiotic. 
     
     
         4 . A method according to claim  7 , wherein the disease is inflammatory bowel disease, ulcerative colitis, collagenous colitis, lymphocytic colitis, Crohn's disease, or irritable bowel syndrome.

Join the waitlist — get patent alerts

Track US2016243117A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.